NATALIE SUAREZ: Open Payments
NPI 1376931972 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 69 payments from 21 companies in 2025. Trend: 2023 $1,767 · 2024 $3,759 · 2025 $2,106
Food & beverage: $2,034Education: $72
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 7 | $611 |
| ABBVIE INC. | 11 | $326 |
| Arcutis Biotherapeutics, Inc. | 11 | $203 |
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| GENZYME CORPORATION | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 2 | $92 |
| Incyte Corporation | 3 | $82 |
| Lilly USA, LLC | 3 | $78 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $61 |
Products named: DAXXIFY, Zoryve, BOTOX, DUPIXENT, SKYRIZI, COSENTYX, Sotyktu, OPZELURA.
Industry payments across FL — which companies pay providers there.
